Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Nebraska Oncology Society
E

2020 ASCO Update on Metastatic/Recurrent HNSCC: What Is the Efficacy and Tolerance of Carboplatin-Cetuximab? Is Single-Agent Chemotherapy Sufficient?

By Nebraska Oncology Society FEATURING Eric Sherman
By Nebraska Oncology Society FEATURING Eric Sherman
15 views
January 5, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

19:39
Pfizer Hematology

The First Treatment Choice Matters

Feat. A. Ip

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss
Head and Neck
08:09

ESMO 2023 Insights: "AIM-HN Study Evaluating Tipifarnib in mHRAS, Re…

Insights from 2023 ESMO Annual Meeting

A. Ho

115 views
18:07

NOS ASCO® 2023 Review: Nasopharynx Cancer

Nebraska Oncology Society

E. Sherman

1.8K views
22:27

NOS ASCO® 2023 Review: Head & Neck Cancer De-Escalation

Nebraska Oncology Society

E. Sherman

237 views
47:18

ASCO 2022 Review of Head & Neck Cancer Updates

Nebraska Oncology Society

E. Sherman

538 views
09:41

ASCO 2020 Review of Transoral Robotic Surgery for OPC : Is 2-yr PFS …

Nebraska Oncology Society

E. Sherman

13 views
09:24

2020 ASCO LA-HNSCC Trials Review: What Is the Efficacy of Weekly CDD…

Nebraska Oncology Society

E. Sherman

13 views
11:38

ASCO 2020 Update on DO-IMRT & HNC Metastatic: Does Change in IMRT Le…

Nebraska Oncology Society

E. Sherman

20 views
04:56

2020 ASCO Update on Metastatic/Recurrent HNSCC: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

15 views
08:09

2020 ASCO Update on RET-Altered Thyroid Cancer: What Is the Efficacy…

Nebraska Oncology Society

E. Sherman

25 views